Home › Oppositional Defiant Disorder › NCT06831123
Pathways 2 Success
Pathways 2 Success: A Study of School-Based Prevention Programs Supporting Positive Adolescent Development
Who can join
Ages 13 to 17 · All sexes
Full eligibility criteria
Inclusion Criteria: 1. A 9th or 10th grade student in a partner school district 2. Referral due to elevated social/emotional risk indicated on a standardized screening tool or a referral from school support staff due to concerns about school-based conduct problems 3. Adolescents and their parents must be fluent in English Exclusion Criteria: 1. Currently receiving special education services (i.e., an IEP) due to a behavioral or emotional disturbance 2. Existing diagnoses of autism spectrum disorder, pervasive developmental disorders, developmental/intellectual disability, or serious psychiatric disorders requiring specialized mental health treatment (e.g., psychosis, bipolar, substance use disorder, etc.)
About the study
This study involves a 3-arm randomized controlled trial designed to investigate the feasibility and acceptability of three preventive interventions designed to reduce risk for escalations in adolescent conduct problems. High school students identified to be at risk for conduct problems will be randomly assigned to one of three intervention options, including a mindfulness-based program, a mindfulness-based program augmented by a new mobile app, and a life skills program. Assessments related to intervention outcomes will be completed by adolescents, parents/guardians, and teachers at baseline, 2 weeks post-intervention, and at a 3-month follow-up.
What is being tested
- L2B (behavioral)
- L2B + App (behavioral)
- skills for success (behavioral)
Sponsor: University of Minnesota · Participants: 120 · Started: Mar 12, 2025
Contact the study team
- Nicole Morrell · Phone: 612-624-2600
Official record on ClinicalTrials.gov — NCT06831123
Locations in the U.S.
| Minnesota | University of Minnesota, Minneapolis |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.